Nevus Unius Lateris (NUL) in a Theree-Year-Old Child Treated by Tretinoin 0.025%, Desoxymethasone 0.25%, and Urea 20% Cream
Downloads
Background: Linear verrucous epidermal nevus is the most frequent variant of the epidermal nevus classification. Linear verrucous epidermal nevus is characterized by the proliferation of epithelium arranged in a configuration that follows Blaschko's line. Nevus unius lateris (NUL) is a variant of the verrucous epidermal nevus, which has a unilateral distribution of lesions. Lesions are usually found at birth or in the first year of life as brown to grey verrucous papules or papillomatous plaques. The management of NUL is challenging as the results are varied and there is a high risk of recurrence. Purpose: to report a case of NUL and its management, especially in children. Case: A 3-year-old girl presented with brownish spots and multiple small lumps on the left buttock that have extended to the left leg since she was 9-days-old. On dermatologic examination, there were numerous hyperpigmented verrucous papules and plaques along the Blaschko line over the affected area. In this case, the diagnosis of NUL, is based on clinical symptoms and dermoscopy examination showed multiple large brown oval or round structures with hyperpigmented brown border. The patient was treated with combination topical therapy of tretinoin 0.025%, corticosteroid desoxymethasone 0.25%, and urea 20% cream, and the lesion improved within four weeks. Discussion: Epidermal nevus is often cosmetically disturbing. The treatment is still challenging and various, including surgical and non-surgical, but none is ideal and could potentially recur over months or years. dst.
Biesbroeck L, Brandling-Bennett H. Update on Epidermal Nevi and Associated Syndromes. Curr Derm Rep. 2016;1:186–94.
Arora B, Khinda V, Bajaj N, Brar G. Congenital Epidermal Nevus. Int J Clin Pediatr Dent. 2016;7(1):43–6.
Kaur L, Mahajan B, Mahajan M, Dhillon S. Nevus Unius Lateris with Bilateral Oral Mucosal Lesions: An Unusual Presentation. Indian Dermatol Online J. 2021;12(2):302–6.
Thomas V, Snavely N, Lee K, Swanson N. Benign epithelial tumors, tamartomas, and hyperplasias. In: Kang S, Amagai M, Bruckner A, Enk A, Margolis D, McMichael A, editors. Fitzpatrick’s Dermatology in General Medicine 9th ed. New York: Mc Graw Hill Education; 2019. p. 1319–36.
Narine K, Carrera L. Nevus Unius Lateris: A Case Report. Cureus. 2019;11(4):1–5.
Brandling-Bennett H, Morel K. Epidermal nevi. Pediatr Clin North Am. 2019;57(5):1177–98.
Chanasumon N, Chayavichitsilp P. Systematized Epidermal Nevus: A Rare Case Report and A Review of Literature. Thai J Dermatol. 2016;33(3):212–6.
Mattia C, Rosa C, Antonio G. Dermoscopy of verrucous epidermal nevus: large brown circles as a novel feature for diagnosis. Int J Dermatol. 2016;55(6):653–6.
Koh M, Lee J, Chong W. Systematized epidermal nevus with epidermolytic hyperkeratosis improving with topical calcipotriol/betametasone dipropionate combination ointment. Pediatr Dermatol. 2016;30:370–3.
Kozarev J. Er: YAG Laser Resurfacing Treatment of Linear Verrucous Epidermal Nevus. J Laser Heal Acad. 2016;(1):61–4.
Abadie Ma, Parveen S, Al-Rubaye M. Effective Treatment of Inflammatory Linear Verrucous Epidermal Nevus with Pulsed 5-Fluoruracil Therapy. J Pigment Disord. 2018;5(2):1–2.
Riahi R, Bush A, Cohen P. Topical Retinoids: Therapeutic Mechanisms in the Treatment of Photodamaged Skin. Am J Clin Dermatol. 2016;17(3):265–76.
Singh S, Rai M, Bhari N, Yadav S. Systematized Inflamatory Linear Verrucous Epidermal Nevus Moderately Responsive to Systemic and Topical Calcipotriol. Paediatric Dermatology. 2018; 19(3):266-8.
Hong JK, Han HS, Yoo KH. Inflammatory Linear Verrucous Epidermal Nevus Sucessfully Treated by a Combination of Tripple Topical Agents. Clinical and Experimental Dermatology. 2021;46(5):940-2.
Gomes RT, Vargas PA, Tomimori J, Lopes MA, Silva AR. Linear Verrucous Epidermal Nevus with Oral Manifestations: report of two cases. Dermatol Online J. 2020; 26(1):1-5.
Copyright (c) 2024 Berkala Ilmu Kesehatan Kulit dan Kelamin
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.